$1.31
-0.01-0.76%
At close: -
$1.35
0.042.90%
After Hours: Feb 7, 9:22 AM EDT
Comments
Loading...
Galectin Therapeutics (GALT) Forecast
NewsEarningsGalectin Therapeutics (GALT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGalectin Therapeutics (NASDAQ:GALT) Stock Quotes, Forecast and News Summary
Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galectin Therapeutics (GALT) stock?
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Who are Galectin Therapeutics (GALT) competitors?
Other companies in Galectin Therapeutics’s space includes: Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Inovio Pharmaceuticals (NASDAQ:INO), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
What is the forecast, or price target, for Galectin Therapeutics (GALT) stock?
There is no analysis for Galectin Therapeutics to provide a consensus price target.
What is the current price for Galectin Therapeutics (GALT)?
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $1.348 last updated February 7, 2025 at 9:22 AM EST.
Does Galectin Therapeutics (GALT) pay a dividend?
There are no upcoming dividends for Galectin Therapeutics.
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.
Is Galectin Therapeutics (GALT) going to split?
There is no upcoming split for Galectin Therapeutics.
What sector and industry does Galectin Therapeutics (GALT) operate in?
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.